3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Prostatic Neoplasms
3
Meningioma
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Pituitary Neoplasms
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Cervical Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neurilemmoma
1
Neoplasms, Adipose Tissue
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Interventions
Pemetrexed
4
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Interleukin-2
3
Carboplatin
3
atezolizumab
2
aldesleukin
2
Pharmaceutical Preparations
2
Ipilimumab
2
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
Thoracoscopy
1
Thoracic Surgery, Video-Assisted
1
Surgery, Computer-Assisted
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Injections
1
Influenza Vaccines
1
Indocyanine Green
1
In Situ Hybridization, Fluorescence
1
Cyclophosphamide
1
Combined Modality Therapy
1
Cerebral Decortication
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mesothelioma, Malignant
×
Proton Therapy
×
Clear all
NCT05655078
2026-03-30
HIT-Meso
University College, London
Phase NA
Recruiting
148 enrolled